A nurse is assessing a toddler who has suspected lead poisoning. Which of the following findings should the nurse expect the client to manifest with acute lead poisoning?

A. Place the infant in an infant seat for 2 hours following the procedure. There is no specific need to place the infant in an infant seat for 2 hours following a lumbar puncture. After the procedure, the infant should be positioned comfortably and safely, but there is no requirement for a specific duration in an infant seat.

B. Hold the infant's chin to his chest and knees to his abdomen during the procedure. This positioning is not appropriate for a lumbar puncture. The correct positioning for a lumbar puncture involves having the infant in a lateral recumbent (side-lying) position with knees flexed up toward the chest, allowing the spine to be flexed and creating space between the vertebrae for the needle insertion.

C. Keep the infant NPO for 6 hours prior to the procedure. Keeping the infant NPO (nothing by mouth) for 6 hours prior to the procedure is not necessary for a lumbar puncture. Infants can continue breastfeeding or formula feeding as usual before the procedure. However, if sedation or anesthesia is planned for the procedure, specific fasting guidelines may apply depending on institutional protocols and the infant's age and health status.

D. Apply a eutectic mixture of lidocaine and prilocaine cream topically 15 minutes prior to the procedure. This is the correct choice. Applying a eutectic mixture of lidocaine and prilocaine cream topically before the procedure helps to numb the skin and reduce pain at the site of the lumbar puncture. It is a standard practice to minimize discomfort for the infant during the procedure.

A. Seasonal affective disorder (SAD): While individuals with SAD experience depressive symptoms that tend to occur seasonally, typically in the winter months, the severity of symptoms is generally less severe compared to MDD. While suicide risk can still be present in individuals with SAD, it is usually lower compared to those with MDD.

B. Persistent depressive disorder (PDD): Persistent depressive disorder, formerly known as dysthymia, is characterized by chronic depressive symptoms that are less severe than those seen in MDD. While individuals with PDD may experience prolonged feelings of sadness and hopelessness, their symptoms may not reach the severity seen in MDD. Therefore, the risk of suicide may be lower in individuals with PDD compared to those with MDD.

C. Major depressive disorder (MDD): Major depressive disorder is characterized by persistent feelings of sadness, hopelessness, and worthlessness, along with a loss of interest or pleasure in activities. Individuals with MDD are at significant risk of suicide, especially if their depressive symptoms are severe. The presence of traction may exacerbate feelings of hopelessness or helplessness in individuals with MDD, further increasing the risk of suicide.

D. Premenstrual dysphoric disorder (PMDD): PMDD is a severe form of premenstrual syndrome (PMS) characterized by significant mood disturbances and other symptoms that occur in the luteal phase of the menstrual cycle. While PMDD can cause distressing symptoms, including depressive mood, irritability, and anxiety, it is typically limited to the premenstrual period and does not carry the same chronicity or severity as MDD. Therefore, the risk of suicide may be lower in individuals with PMDD compared to those with MDD.